USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I is a research paper published in Journal of Clinical Investigation (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01DK126908,R01DK120330,R01CA257520,R01CA284740
NIH
Grant: CA232347
NCI NIH HHS
Grant: R01 CA298232
NIDDK NIH HHS
Grant: R01 DK126908
NCI NIH HHS
Grant: R01 CA288387
NCI NIH HHS
Grant: UH3 CA256967
NCI NIH HHS
Grant: R01 CA232347
NCI NIH HHS
Grant: R01 CA257520
NIDDK NIH HHS
Grant: R01 DK120330
NCI NIH HHS
Grant: R01 CA245699
NCI NIH HHS
Grant: R01 CA284740
NIAID NIH HHS
Grant: R01 AI167272
NCI NIH HHS
Grant: UG3 CA256967
MeSH Terms
Keywords